Percutaneous Right Ventricular Assist Device for Managing Decompensated Right Heart Failure in Pulmonary Arterial Hypertension

Management of pulmonary arterial hypertension (PAH) with concomitant decompensated right-sided heart failure refractory to conventional pharmacotherapy presents a significant and multifaceted medical challenge. Although extracorporeal membrane oxygenation has been proven as an effective emergency intervention for unresponsive cardiopulmonary failure, the alternative use of a right ventricular assist device (RVAD) holds promise in the appropriate setting. We present a case of RVAD use in a patient with life-threatening acute PAH who was successfully bridged through critical decompensation to discharge without the need for more invasive procedures.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-01-27
DOI
https://doi.org/10.7759/cureus.78106
Citations
1
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Percutaneous Right Ventricular Assist Device for Managing Decompensated Right Heart Failure in Pulmonary Arterial Hypertension

WATIPA MAKHUMALO, Ishan Abdullah, Devon Kelley, Jalil Ahari et al.
1 citations
Cureus
Pulmonary Hypertension Research and Treatments
1.52
article

Percutaneous Right Ventricular Assist Device for Managing Decompensated Right Heart Failure in Pulmonary Arterial Hypertension

WATIPA MAKHUMALO, Ishan Abdullah, Devon Kelley, Jalil Ahari, Ahmed Abdelmonem
article en
1 citations

Abstract

Management of pulmonary arterial hypertension (PAH) with concomitant decompensated right-sided heart failure refractory to conventional pharmacotherapy presents a significant and multifaceted medical challenge. Although extracorporeal membrane oxygenation has been proven as an effective emergency intervention for unresponsive cardiopulmonary failure, the alternative use of a right ventricular assist device (RVAD) holds promise in the appropriate setting. We present a case of RVAD use in a patient with life-threatening acute PAH who was successfully bridged through critical decompensation to discharge without the need for more invasive procedures.

CureusVol. 17(1)
George Washington University (US)
Good health and well-being
Openalex Percentile: Top 22%
Pulmonary Hypertension Research and Treatments
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.